Involvement of per- and polyfluoroalkyl compounds in tumor development

Maija Pesonen,Kirsi Vähäkangas
DOI: https://doi.org/10.1007/s00204-024-03685-7
2024-03-14
Archives of Toxicology
Abstract:Per- and polyfluoroalkyl substances (PFAS) are a large group of synthetic persistent chemicals, which are used in many industrial and commercial applications. Hundreds of different PFAS have been identified in the environment and they are commonly found also in human blood. Due to the chemical stability and extensive use, PFAS pose a risk for human health and wildlife. Mounting evidence indicates that PFAS-exposure adversely affects many organs including liver, kidney, and reproductive tissues and induces tumors in laboratory rodents. Epidemiological studies show association between PFAS-exposure and some tumors also in humans. Effects of PFAS-exposure are complex and obviously do not depend only on the concentration and the structure of PFAS, but also on age and sex of the exposed individuals. It has been difficult to show a causal link between PFAS-exposure and tumors. Moreover, molecular mechanisms of the PFAS effects in different tissues are poorly understood. PFAS are not directly mutagenic and they do not induce formation of DNA binding metabolites, and thus are assumed to act more through non-genotoxic mechanisms. In this review, we discuss the involvement of PFAS-compounds in tumor development in tissues where PFAS exposure has been associated with cancer in epidemiological and animal studies (liver, kidney, testicle and breast). We will focus on molecular pathways and mechanisms related to tumor formation following PFAS-exposure.
toxicology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore the role of perfluoro - and polyfluoroalkyl substances (PFAS) in tumor development. Specifically, the article mainly focuses on the following aspects: 1. **Health risks of PFAS**: PFAS are a class of persistent chemicals widely present in the environment and human body. Due to their chemical stability and wide - ranging applications, they pose a potential threat to human health and wild animals. Increasing evidence shows that PFAS exposure can have adverse effects on multiple organs (such as the liver, kidneys, reproductive tissues, etc.), and may induce tumor formation in experimental animals. 2. **Relationship between PFAS and tumors**: Epidemiological studies indicate that there is an association between PFAS exposure and certain types of human tumors, especially in occupationally exposed populations and those living in PFAS - polluted environments. However, it is very difficult to prove the causal relationship between PFAS exposure and tumors, and its molecular mechanism is still unclear. 3. **Non - genotoxic mechanisms**: PFAS are not direct mutagens and do not induce the formation of DNA - binding metabolites. Therefore, it is speculated that they mainly act through non - genotoxic mechanisms. The article focuses on the molecular pathways and mechanisms of tumor formation in tissues such as the liver, kidneys, testes, and mammary glands after PFAS exposure. 4. **Mechanism research in specific tissues**: - **Liver**: PFAS exposure is associated with increased liver enzyme levels, bile acid metabolism disorders, and lipid accumulation. In addition, PFAS affects cell cycle, lipid metabolism, transport, apoptosis, and cell proliferation by activating the peroxisome proliferator - activated receptor α (PPARα) signaling pathway. - **Kidneys**: PFAS exposure is associated with kidney function impairment, increased uric acid levels, and increased tumor risk. PFAS also affects lipid and energy metabolism, leading to oxidative stress, apoptosis, and hypertrophy of renal tubular epithelial cells. - **Testes**: PFAS exposure is associated with Leydig cell tumors in the testes, which is closely related to hormonal imbalance (especially an increased estrogen/testosterone ratio). PFAS may affect hormonal balance by down - regulating the expression of steroid - generating enzymes or up - regulating the expression of hepatic aromatase (CYP19A1). - **Mammary glands**: PFAS exposure is associated with an increased risk of breast cancer, especially for ER+/PR+ breast tumors. PFAS has estrogen - like properties and can enhance ER transcriptional activation and accelerate cell proliferation. 5. **Discussion of molecular mechanisms**: The article discusses in detail the specific molecular mechanisms by which PFAS induces tumors in the above - mentioned tissues, including gene expression changes, signal pathway regulation, epigenetic modification, etc. In summary, this paper aims to systematically review the molecular mechanisms by which PFAS induces tumor development in different tissues, in order to provide a theoretical basis for future research and scientific evidence for assessing the health risks of PFAS.